Range
- - -
Vol / Avg.
-/0.2K
Div / Yield
-
52 Wk
3.1 - 11.3
Mkt Cap
518.8M
Payout Ratio
-
Open
-
P/E
-
Shares
45.9M
Outstanding
-
Total Float
-
There is no Press for this Ticker
Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence and optogenetics, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. The group focus is in ophthalmology where it develops product candidates to restore eyesight to patients suffering from retinal diseases that would otherwise lead to blindness.

Related Companies

TickerCompanyChg %Mkt Cap
GSGTFGensight Biologics0%518.8M

Gensight Biologics Company Questions & Answers

Q

How do I buy Gensight Biologics (GSGTF) stock?

A

You can purchase shares of Gensight Biologics (OTC: GSGTF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Gensight Biologics's (GSGTF) main competitors?

A

There are no as such competitors for Gensight Biologics.

Q

What is the target price for Gensight Biologics?

A

There is no analysis for Gensight Biologics

Q

How much is Gensight Biologics (GSGTF) stock ?

A

The stock price for Gensight Biologics (OTC: GSGTF) is $11.3 last updated Thu May 06 2021 14:40:37 GMT+0000 (Coordinated Universal Time).

Q

When is the next Gensight Biologics (GSGTF) dividend?

A

There are no upcoming dividends for Gensight Biologics.

Q

When is Gensight Biologics (OTC:GSGTF) reporting earnings?

A

There are no earnings for Gensight Biologics

Q

When is the upcoming split for GSGTF?

A

There is no upcoming split for Gensight Biologics.